Luis Alberto Alcaraz Lopez
FDA import alert and refusal historyGuadalajara, MexicoFEI 3001743733
As of October 26, 2026, Luis Alberto Alcaraz Lopez (Guadalajara, Mexico) is on the red list of FDA Import Alert 45-02 (Foods with illegal or undeclared colors) for lollipop (without chocolate), published by FDA on September 18, 2009, and has no FDA import refusals recorded since October 2016.
Data from FDA public records, last checked . Request a correction
Current status
- Import alerts
- IA 45-02 · red list
- Last import refusal
- None since October 2016
- Last warning letter
- None found
- Last inspection
- None on record
Every FDA record for Luis Alberto Alcaraz Lopez
1 record, newest first. Each line links to the FDA page it came from.
2009
- Import alert listingListed on Import Alert 45-02red listLollipop (without Chocolate)Source
Questions about Luis Alberto Alcaraz Lopez
- Is Luis Alberto Alcaraz Lopez on an FDA import alert?
- Yes. As of October 26, 2026, Luis Alberto Alcaraz Lopez is on the red list of FDA Import Alert 45-02, “Foods with illegal or undeclared colors”, for lollipop (without chocolate); FDA published the listing on September 18, 2009.
- Has FDA refused shipments from Luis Alberto Alcaraz Lopez?
- No FDA import refusals for Luis Alberto Alcaraz Lopez appear in FDA's refusal data since October 2016, as of October 26, 2026.
- What is Luis Alberto Alcaraz Lopez's FEI number?
- Luis Alberto Alcaraz Lopez's FDA Establishment Identifier (FEI) is 3001743733.
- Can shipments from Luis Alberto Alcaraz Lopez still enter the U.S.?
- Shipments of lollipop (without chocolate) from Luis Alberto Alcaraz Lopez can be detained without physical examination under Import Alert 45-02; FDA releases them only if evidence shows they do not have the listed violation. Importers must consider this listing in their FSVP evaluation (21 CFR 1.505).
Buying from Luis Alberto Alcaraz Lopez?
Watch it and get the FDA record the day it changes. Free for one supplier.
SupplierRadar is not affiliated with the U.S. Food and Drug Administration. Data comes from public FDA records and may contain errors. This is not legal advice; importers remain responsible for their supplier evaluations.